PharmStar expects to be a leader in the pain management field, and to capture a substantial segment of the analgesic, cardio protective, anti-thrombotic and antipyretic pharmacotherapeutic market, owing to AQUAPRIN   and other line extension products  significant competitive advantages.

PharmStar's initial base product that has been perfected is AQUAPRIN and INSTA-PRIN.  Additional line extension products are now in development.

Aspirin, (acetylsalicylic acid), is not water soluble and slow to enter the blood stream. Since it is acidic, it causes  bleeding in the digestion track as it is broken down by enzymes. 

The AQUAPRIN  formulation instantly dissolves  aspirin on contact with water making it a, fast-acting, non-acidic, (is antacid), safer, more therapeutically available, liquid derivative of aspirin. In this form, it virtually eliminates irritation to the GI-tract, and is a more effective and efficient method of delivering salicylates into the blood stream. This achieves peak blood plasma levels of the drug in 5 to 7 minutes.  Moreover, it contains therapeutically active levels of potassium, which acts also as an antacid in neutralizing stomach acid. Potassium also lowers blood pressure and helps to dilate blood vessels allowing for better blood circulation.